- Home
- KODK vs CRMD Comparison
KODK vs CRMD Comparison
Compare KODK & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KODK
- CRMD
- Stock Information
- Founded
- KODK 1880
- CRMD 2006
- Country
- KODK United States
- CRMD United States
- Employees
- KODK N/A
- CRMD N/A
- Industry
- KODK Business Services
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- KODK Consumer Discretionary
- CRMD Health Care
- Exchange
- KODK Nasdaq
- CRMD Nasdaq
- Market Cap
- KODK 649.6M
- CRMD 645.0M
- IPO Year
- KODK N/A
- CRMD 2010
- Fundamental
- Price
- KODK $7.06
- CRMD $10.13
- Analyst Decision
- KODK
- CRMD Strong Buy
- Analyst Count
- KODK 0
- CRMD 6
- Target Price
- KODK N/A
- CRMD $15.67
- AVG Volume (30 Days)
- KODK 1.1M
- CRMD 906.0K
- Earning Date
- KODK 03-13-2025
- CRMD 03-11-2025
- Dividend Yield
- KODK N/A
- CRMD N/A
- EPS Growth
- KODK 0.52
- CRMD N/A
- EPS
- KODK 0.71
- CRMD N/A
- Revenue
- KODK $1,052,000,000.00
- CRMD $12,262,234.00
- Revenue This Year
- KODK N/A
- CRMD N/A
- Revenue Next Year
- KODK N/A
- CRMD $234.92
- P/E Ratio
- KODK $9.96
- CRMD N/A
- Revenue Growth
- KODK N/A
- CRMD 41184.20
- 52 Week Low
- KODK $3.39
- CRMD $3.03
- 52 Week High
- KODK $8.24
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- KODK 45.69
- CRMD 44.90
- Support Level
- KODK $7.05
- CRMD $9.79
- Resistance Level
- KODK $8.24
- CRMD $11.28
- Average True Range (ATR)
- KODK 0.47
- CRMD 0.51
- MACD
- KODK -0.06
- CRMD -0.05
- Stochastic Oscillator
- KODK 4.07
- CRMD 23.84
About KODK Eastman Kodak Company Common New
Eastman Kodak Co is a United States-based company. The company operates via several business segments; Print, Brand, and Advanced Materials and Chemicals. The Print segment which derives the majority of revenue includes products like digital offset plate offerings and computer-to-plate imaging solutions, high-quality digital printing solutions using electrically charged toner-based technology, production press systems, consumables, inkjet components, software and services. Geographically, the company generates revenue from the United States, Canada, Europe, Middle East and Africa, Asia Pacific, and Latin America.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.